{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:32:21Z","timestamp":1795087941025,"version":"4.10.2"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT101159"],"award-info":[{"award-number":["WT101159"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The function of interleukin-22 (IL-22) in intestinal barrier homeostasis remains controversial. Here, we map the transcriptional landscape regulated by IL-22 in human colonic epithelial organoids and evaluate the biological, functional and clinical significance of the IL-22 mediated pathways in ulcerative colitis (UC). We show that IL-22 regulated pro-inflammatory pathways are involved in microbial recognition, cancer and immune cell chemotaxis; most prominently those involving CXCR2\n                    <jats:sup>+<\/jats:sup>\n                    neutrophils. IL-22-mediated transcriptional regulation of CXC-family neutrophil-active chemokine expression is highly conserved across species, is dependent on STAT3 signaling, and is functionally and pathologically important in the recruitment of CXCR2\n                    <jats:sup>+<\/jats:sup>\n                    neutrophils into colonic tissue. In UC patients, the magnitude of enrichment of the IL-22 regulated transcripts in colonic biopsies correlates with colonic neutrophil infiltration and is enriched in non-responders to ustekinumab therapy. Our data provide further insights into the biology of IL-22 in human disease and highlight its function in the regulation of pathogenic immune pathways, including neutrophil chemotaxis. The transcriptional networks regulated by IL-22 are functionally and clinically important in UC, impacting patient trajectories and responsiveness to biological intervention.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-33331-8","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T09:03:00Z","timestamp":1664787780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":157,"title":["Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4864-2208","authenticated-orcid":false,"given":"Polychronis","family":"Pavlidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Tsakmaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Pantazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6752-5432","authenticated-orcid":false,"given":"Domenico","family":"Cozzetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1378-1219","authenticated-orcid":false,"given":"Jonathan","family":"Digby- Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Alberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Caroline Costa","family":"Sa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7176-8883","authenticated-orcid":false,"given":"Umar","family":"Niazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9382-8429","authenticated-orcid":false,"given":"Joshua","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-4956","authenticated-orcid":false,"given":"Christopher","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor","family":"Saqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Madgwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5600-8189","authenticated-orcid":false,"given":"Agatha","family":"Treveil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1717-996X","authenticated-orcid":false,"given":"Tamas","family":"Korcsmaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas T.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-4743","authenticated-orcid":false,"given":"Graham M.","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4335-8403","authenticated-orcid":false,"given":"Gavin","family":"Bewick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3231-6950","authenticated-orcid":false,"given":"Nick","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"33331_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/MIB.0b013e31827f27ae","volume":"19","author":"M Bewtra","year":"2013","unstructured":"Bewtra, M., Kaiser, L. M., Tenhave, T. & Lewis, J. D. Crohn\u2019s disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis. Inflamm. Bowel Dis. 19, 599\u2013613 (2013).","journal-title":"Inflamm. Bowel Dis."},{"key":"33331_CR2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/jso.21505","volume":"101","author":"MN Kulaylat","year":"2010","unstructured":"Kulaylat, M. N. & Dayton, M. T. Ulcerative colitis and cancer. J. Surg. Oncol. 101, 706\u2013712 (2010).","journal-title":"J. Surg. Oncol."},{"key":"33331_CR3","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.immuni.2019.03.017","volume":"50","author":"M Friedrich","year":"2019","unstructured":"Friedrich, M., Pohin, M. & Powrie, F. Cytokine networks in the pathophysiology of inflammatory bowel disease. Immunity 50, 992\u20131006 (2019).","journal-title":"Immunity"},{"key":"33331_CR4","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","volume":"381","author":"BE Sands","year":"2019","unstructured":"Sands, B. E. et al. Ustekinumab as induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 381, 1201\u20131214 (2019).","journal-title":"N. Engl. J. Med."},{"key":"33331_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1084\/jem.20030451","volume":"199","author":"E Lee","year":"2004","unstructured":"Lee, E. et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J. Exp. Med. 199, 125\u2013130 (2004).","journal-title":"J. Exp. Med."},{"key":"33331_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua, D. J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744\u2013748 (2003).","journal-title":"Nature"},{"key":"33331_CR7","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock, J. P. et al. IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells. Nat. Med. 18, 1069\u20131076 (2012).","journal-title":"Nat. Med."},{"key":"33331_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.immuni.2006.05.017","volume":"25","author":"HH Uhlig","year":"2006","unstructured":"Uhlig, H. H. et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25, 309\u2013318 (2006).","journal-title":"Immunity"},{"key":"33331_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.immuni.2010.08.010","volume":"33","author":"PP Ahern","year":"2010","unstructured":"Ahern, P. P. et al. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 33, 279\u2013288 (2010).","journal-title":"Immunity"},{"key":"33331_CR10","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.4049\/jimmunol.166.12.7563","volume":"166","author":"MT Wiekowski","year":"2001","unstructured":"Wiekowski, M. T. et al. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J. Immunol. 166, 7563\u20137570 (2001).","journal-title":"J. Immunol."},{"key":"33331_CR11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.immuni.2012.09.008","volume":"37","author":"N Powell","year":"2012","unstructured":"Powell, N. et al. The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity 37, 674\u2013684 (2012).","journal-title":"Immunity"},{"key":"33331_CR12","doi-asserted-by":"publisher","first-page":"E2559","DOI":"10.1073\/pnas.1408540111","volume":"111","author":"J Ermann","year":"2014","unstructured":"Ermann, J., Staton, T., Glickman, J. N., de Waal Malefyt, R. & Glimcher, L. H. Nod\/Ripk2 signaling in dendritic cells activates IL-17A-secreting innate lymphoid cells and drives colitis in T-bet-\/-.Rag2-\/- (TRUC) mice. Proc. Natl Acad. Sci. USA 111, E2559\u2013E2566 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33331_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish, C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med 201, 233\u2013240 (2005).","journal-title":"J. Exp. Med"},{"key":"33331_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nature16460","volume":"528","author":"CA Lindemans","year":"2015","unstructured":"Lindemans, C. A. et al. Interleukin-22 promotes intestinal-stem-cell- mediated epithelial regeneration. Nature, 528, 1\u201318 (2015).","journal-title":"Nature"},{"key":"33331_CR15","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/gutjnl-2019-318483","volume":"69","author":"N Powell","year":"2019","unstructured":"Powell, N. et al. Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells. Gut 69, 578\u2013590 (2019).","journal-title":"Gut"},{"key":"33331_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer, A., Green, J., Pollard, J. Jr. & Tugendreich, S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30, 523\u2013530 (2014).","journal-title":"Bioinformatics"},{"key":"33331_CR17","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.4049\/jimmunol.179.12.8098","volume":"179","author":"K Kreymborg","year":"2007","unstructured":"Kreymborg, K. et al. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179, 8098\u20138104 (2007).","journal-title":"J. Immunol."},{"key":"33331_CR18","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","volume":"445","author":"Y Zheng","year":"2007","unstructured":"Zheng, Y. et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648\u2013651 (2007).","journal-title":"Nature"},{"key":"33331_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ni.2031","volume":"12","author":"M El-Behi","year":"2011","unstructured":"El-Behi, M. et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12, 568\u2013575 (2011).","journal-title":"Nat. Immunol."},{"key":"33331_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/imr.12027","volume":"252","author":"S Rutz","year":"2013","unstructured":"Rutz, S., Eidenschenk, C. & Ouyang, W. IL-22, not simply a Th17 cytokine. Immunol. Rev. 252, 116\u2013132 (2013).","journal-title":"Immunol. Rev."},{"key":"33331_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen, S. L., Jain, R., Garg, A. V. & Cua, D. J. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14, 585\u2013600 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"33331_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9010","volume":"6","author":"SU Seo","year":"2015","unstructured":"Seo, S. U. et al. Intestinal macrophages arising from CCR2(+) monocytes control pathogen infection by activating innate lymphoid cells. Nat. Commun. 6, 8010 (2015).","journal-title":"Nat. Commun."},{"key":"33331_CR23","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1767","volume":"10","author":"T Duhen","year":"2009","unstructured":"Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A. & Sallusto, F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 10, 857\u2013863 (2009).","journal-title":"Nat. Immunol."},{"key":"33331_CR24","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1053\/j.gastro.2015.04.017","volume":"149","author":"N Powell","year":"2015","unstructured":"Powell, N. et al. Interleukin 6 increases production of cytokines by colonic innate lymphoid cells in mice and patients with chronic intestinal inflammation. Gastroenterology 149, 456\u2013467.e415 (2015).","journal-title":"Gastroenterology"},{"key":"33331_CR25","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1084\/jem.20140678","volume":"211","author":"RS Longman","year":"2014","unstructured":"Longman, R. S. et al. CX 3CR1 +mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J. Exp. Med. 211, 1571\u20131583 (2014).","journal-title":"J. Exp. Med."},{"key":"33331_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/gut.47.3.404","volume":"47","author":"K Geboes","year":"2000","unstructured":"Geboes, K. et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 47, 404\u2013409 (2000).","journal-title":"Gut"},{"key":"33331_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"33331_CR28","doi-asserted-by":"crossref","unstructured":"Czarnewski, P. et al. Conserved transcriptomic profile between mouse and human colitis allows unsupervised patient stratification. Nat. Commun. 1\u201311 (2019).","DOI":"10.1038\/s41467-019-10769-x"},{"key":"33331_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cell.2007.08.017","volume":"131","author":"WS Garrett","year":"2007","unstructured":"Garrett, W. S. et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131, 33\u201345 (2007).","journal-title":"Cell"},{"key":"33331_CR30","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","volume":"178","author":"CS Smillie","year":"2019","unstructured":"Smillie, C. S. et al. Intra- and inter-cellular rewiring of the human colon during ulcerative colitis. Cell 178, 714\u2013730.e722 (2019).","journal-title":"Cell"},{"key":"33331_CR31","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1084\/jem.20082683","volume":"206","author":"G Pickert","year":"2009","unstructured":"Pickert, G. et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206, 1465\u20131472 (2009).","journal-title":"J. Exp. Med."},{"key":"33331_CR32","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.intimp.2004.01.008","volume":"4","author":"ML Nagalakshmi","year":"2004","unstructured":"Nagalakshmi, M. L., Rascle, A., Zurawski, S., Menon, S. & de Waal Malefyt, R. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int. Immunopharmacol. 4, 679\u2013691 (2004).","journal-title":"Int. Immunopharmacol."},{"key":"33331_CR33","doi-asserted-by":"publisher","first-page":"33676","DOI":"10.1074\/jbc.M204204200","volume":"277","author":"D Lejeune","year":"2002","unstructured":"Lejeune, D. et al. Interleukin-22 (IL-22) activates the JAK\/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J. Biol. Chem. 277, 33676\u201333682 (2002).","journal-title":"J. Biol. Chem."},{"key":"33331_CR34","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.4049\/jimmunol.1303076","volume":"193","author":"I Backert","year":"2014","unstructured":"Backert, I. et al. STAT3 activation in Th17 and Th22 cells controls IL-22-Mediated Epithelial Host Defense during Infectious Colitis. J. Immunol. 193, 3779\u20133791 (2014).","journal-title":"J. Immunol."},{"key":"33331_CR35","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","volume":"376","author":"WJ Sandborn","year":"2017","unstructured":"Sandborn, W. J. et al. Tofacitinib as induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 376, 1723\u20131736 (2017).","journal-title":"N. Engl. J. Med."},{"key":"33331_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41575-019-0228-5","volume":"17","author":"JL Digby-Bell","year":"2020","unstructured":"Digby-Bell, J. L., Atreya, R., Monteleone, G. & Powell, N. Interrogating host immunity to predict treatment response in inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 17, 9\u201320 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"33331_CR37","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/ecco-jcc\/jjab050","volume":"15","author":"B Verstockt","year":"2021","unstructured":"Verstockt, B. et al. Results of the Seventh Scientific Workshop of ECCO: Precision medicine in IBD - disease outcome and response to therapy. J Crohns Colitis 15, 1431\u20131442 (2021).","journal-title":"J Crohns Colitis"},{"key":"33331_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/ibd.21697","volume":"18","author":"W Reinisch","year":"2012","unstructured":"Reinisch, W. et al. Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and \u22122 extension studies. Inflamm. Bowel Dis. 18, 201\u2013211 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"33331_CR39","first-page":"CD007571","volume":"8","author":"SJ Bickston","year":"2014","unstructured":"Bickston, S. J. et al. Vedolizumab for induction and maintenance of remission in ulcerative colitis. Cochrane Database Syst. Rev. 8, CD007571 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"33331_CR40","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa1905725","volume":"381","author":"BE Sands","year":"2019","unstructured":"Sands, B. E. et al. Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis. N. Engl. J. Med. 381, 1215\u20131226 (2019).","journal-title":"N. Engl. J. Med."},{"key":"33331_CR41","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.ebiom.2019.01.027","volume":"40","author":"B Verstockt","year":"2019","unstructured":"Verstockt, B. et al. Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease. EBioMedicine 40, 733\u2013742 (2019).","journal-title":"EBioMedicine"},{"key":"33331_CR42","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1053\/j.gastro.2015.07.002","volume":"149","author":"P Biancheri","year":"2015","unstructured":"Biancheri, P. et al. Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease. Gastroenterology 149, 1564\u20131574.e1563 (2015).","journal-title":"Gastroenterology"},{"key":"33331_CR43","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","volume":"141","author":"T Sato","year":"2011","unstructured":"Sato, T. et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology 141, 1762\u20131772 (2011).","journal-title":"Gastroenterology"},{"key":"33331_CR44","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36\u201313 (2013).","journal-title":"Genome Biol."},{"key":"33331_CR45","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"33331_CR46","unstructured":"Kruschke, J. Doing Bayesian Data Analysis (Academic Press, 2010)."},{"key":"33331_CR47","doi-asserted-by":"crossref","unstructured":"Gelman, A. et al. Bayesian Data Analysis, 3rd edn. (CRC Press, 2013).","DOI":"10.1201\/b16018"},{"key":"33331_CR48","unstructured":"Team, R.C. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, 2013). https:\/\/www.R-project.org\/."},{"key":"33331_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v076.i01","volume":"76","author":"B Carpenter","year":"2017","unstructured":"Carpenter, B. et al. Stan: a probabilistic programming language. J. Stat. Softw. 76, 1\u20133 (2017).","journal-title":"J. Stat. Softw."},{"key":"33331_CR50","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","volume":"125","author":"Y Benjamini","year":"2001","unstructured":"Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N. & Golani, I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125, 279\u2013284 (2001).","journal-title":"Behav. Brain Res."},{"key":"33331_CR51","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"33331_CR52","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607\u2013D613 (2019).","journal-title":"Nucleic Acids Res."},{"key":"33331_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Haenzelmann","year":"2013","unstructured":"Haenzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-Seq data. Bmc Bioinform. 14, 7 (2013).","journal-title":"Bmc Bioinform."},{"key":"33331_CR54","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33331_CR55","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"33331_CR56","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011).","journal-title":"Bioinformatics"},{"key":"33331_CR57","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1097\/MIB.0000000000000535","volume":"21","author":"W Vanhove","year":"2015","unstructured":"Vanhove, W. et al. Strong upregulation of AIM2 and IFI16 inflammasomes in the mucosa of patients with active inflammatory bowel disease. Inflamm. Bowel Dis. 21, 2673\u20132682 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"33331_CR58","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/ajg.2011.83","volume":"106","author":"G Toedter","year":"2011","unstructured":"Toedter, G. et al. Gene expression profiling and response signatures associated with differential responses to infliximab treatment in ulcerative colitis. Am. J. Gastroenterol. 106, 1272\u20131280 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"33331_CR59","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1136\/gut.2009.178665","volume":"58","author":"I Arijs","year":"2009","unstructured":"Arijs, I. et al. Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis. Gut 58, 1612\u20131619 (2009).","journal-title":"Gut"},{"key":"33331_CR60","doi-asserted-by":"crossref","unstructured":"Arijs, I. et al. Effect of vedolizumab (anti-\u03b14\u03b27-integrin) therapy on histological healing and mucosal gene expression in patients with UC. Gut, gutjnl-2016-312293-312211 (2016).","DOI":"10.1136\/gutjnl-2016-312293"},{"key":"33331_CR61","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","volume":"75","author":"R K\u00fchn","year":"1993","unstructured":"K\u00fchn, R., L\u00f6hler, J., Rennick, D., Rajewsky, K. & M\u00fcller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263\u2013274 (1993).","journal-title":"Cell"},{"key":"33331_CR62","first-page":"238","volume":"69","author":"HS Cooper","year":"1993","unstructured":"Cooper, H. S., Murthy, S. N., Shah, R. S. & Sedergran, D. J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Investig. 69, 238\u2013249 (1993).","journal-title":"Lab. Investig."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33331-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33331-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33331-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T10:17:23Z","timestamp":1664792243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33331-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["33331"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-33331-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"20 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.L., F.Y., A.C.C.S., J.F. were all employed by Janssen Pharmaceuticals. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5820"}}